[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fdj_Ql7ijMX89HgNaV0B7GDadLnwh8Uq3ONh9pAuJRMg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":53,"rows":60},"University Hospital, Akershus",[4],121,false,32,2,112467,8,101,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Heart Failure",5,{"name":18,"count":19},"Breast Cancer",3,{"name":21,"count":19},"Bipolar Disorder",{"name":23,"count":19},"Hip Fractures",{"name":25,"count":19},"Substance Use Disorders",{"name":27,"count":9},"Depressive Disorder",{"name":29,"count":9},"Dementia",{"name":31,"count":9},"Femoral Neck Fractures",[33,38,43,48],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT04870866","NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia","2024-09-03","Nicotinamide ribonucleoside",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT05025098","Precision Therapy Versus Standard Therapy in AML and MDS in Elderly","2026-06-10","Standard therapy",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT05504252","METIMMOX-2: Metastatic pMMR\u002FMSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin","2028-01-31","Nivolumab",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT06712641","Aminoglycosides in Early Sepsis","2028-06","Gentamicin + narrow spectrum betalactam",[54,55,56,57,58,59],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[61,88,106,124,161,183,207,225,243,272,290,317,343,368,394,418,456,493,518,543,568,586,616,634,652,670,688],{"intervention":52,"totalTrials":62,"cells":63},1,{"EARLY_PHASE1":64,"PHASE1":67,"PHASE2":69,"PHASE3":71,"PHASE4":73,"NA":86},{"trials":65,"activeCount":66},[],0,{"trials":68,"activeCount":66},[],{"trials":70,"activeCount":66},[],{"trials":72,"activeCount":66},[],{"trials":74,"activeCount":62,"soonestReadout":51},[75],{"nctId":49,"briefTitle":50,"status":76,"phases":77,"primaryCompletion":51,"completion":78,"start":79,"enrollment":80,"conditions":81,"interventions":83},"RECRUITING",[58],"2033-05","2026-04-23",1900,[82],"Sepsis",[52,84,85],"Cefotaxime","Piperacillin-tazobactam",{"trials":87,"activeCount":66},[],{"intervention":84,"totalTrials":62,"cells":89},{"EARLY_PHASE1":90,"PHASE1":92,"PHASE2":94,"PHASE3":96,"PHASE4":98,"NA":104},{"trials":91,"activeCount":66},[],{"trials":93,"activeCount":66},[],{"trials":95,"activeCount":66},[],{"trials":97,"activeCount":66},[],{"trials":99,"activeCount":62,"soonestReadout":51},[100],{"nctId":49,"briefTitle":50,"status":76,"phases":101,"primaryCompletion":51,"completion":78,"start":79,"enrollment":80,"conditions":102,"interventions":103},[58],[82],[52,84,85],{"trials":105,"activeCount":66},[],{"intervention":85,"totalTrials":62,"cells":107},{"EARLY_PHASE1":108,"PHASE1":110,"PHASE2":112,"PHASE3":114,"PHASE4":116,"NA":122},{"trials":109,"activeCount":66},[],{"trials":111,"activeCount":66},[],{"trials":113,"activeCount":66},[],{"trials":115,"activeCount":66},[],{"trials":117,"activeCount":62,"soonestReadout":51},[118],{"nctId":49,"briefTitle":50,"status":76,"phases":119,"primaryCompletion":51,"completion":78,"start":79,"enrollment":80,"conditions":120,"interventions":121},[58],[82],[52,84,85],{"trials":123,"activeCount":66},[],{"intervention":47,"totalTrials":9,"cells":125},{"EARLY_PHASE1":126,"PHASE1":128,"PHASE2":130,"PHASE3":155,"PHASE4":157,"NA":159},{"trials":127,"activeCount":66},[],{"trials":129,"activeCount":66},[],{"trials":131,"activeCount":62,"soonestReadout":46},[132,144],{"nctId":133,"briefTitle":134,"status":135,"phases":136,"primaryCompletion":137,"completion":137,"start":138,"enrollment":139,"conditions":140,"interventions":142},"NCT03388190","METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin","COMPLETED",[56],"2024-03-18","2018-05-29",80,[141],"Colorectal Cancer Metastatic",[47,143],"FLOX",{"nctId":44,"briefTitle":45,"status":145,"phases":146,"primaryCompletion":46,"completion":147,"start":148,"enrollment":139,"conditions":149,"interventions":153},"ACTIVE_NOT_RECRUITING",[56],"2028-03-01","2022-10-05",[150,151,152],"Colorectal Adenocarcinoma","Mucinous Adenocarcinoma","Signet Ring Cell Adenocarcinoma",[47,154],"Oxaliplatin",{"trials":156,"activeCount":66},[],{"trials":158,"activeCount":66},[],{"trials":160,"activeCount":66},[],{"intervention":37,"totalTrials":62,"cells":162},{"EARLY_PHASE1":163,"PHASE1":165,"PHASE2":167,"PHASE3":177,"PHASE4":179,"NA":181},{"trials":164,"activeCount":66},[],{"trials":166,"activeCount":66},[],{"trials":168,"activeCount":62,"soonestReadout":36},[169],{"nctId":34,"briefTitle":35,"status":145,"phases":170,"primaryCompletion":36,"completion":171,"start":172,"enrollment":173,"conditions":174,"interventions":176},[56],"2027-06-16","2019-06-05",13,[175],"Ataxia Telangiectasia",[37],{"trials":178,"activeCount":66},[],{"trials":180,"activeCount":66},[],{"trials":182,"activeCount":66},[],{"intervention":42,"totalTrials":62,"cells":184},{"EARLY_PHASE1":185,"PHASE1":187,"PHASE2":189,"PHASE3":201,"PHASE4":203,"NA":205},{"trials":186,"activeCount":66},[],{"trials":188,"activeCount":66},[],{"trials":190,"activeCount":62,"soonestReadout":41},[191],{"nctId":39,"briefTitle":40,"status":76,"phases":192,"primaryCompletion":41,"completion":193,"start":194,"enrollment":195,"conditions":196,"interventions":199},[56],"2027-06-10","2021-06-22",36,[197,198],"AML, Adult","MDS",[42,200],"Precision therapy",{"trials":202,"activeCount":66},[],{"trials":204,"activeCount":66},[],{"trials":206,"activeCount":66},[],{"intervention":200,"totalTrials":62,"cells":208},{"EARLY_PHASE1":209,"PHASE1":211,"PHASE2":213,"PHASE3":219,"PHASE4":221,"NA":223},{"trials":210,"activeCount":66},[],{"trials":212,"activeCount":66},[],{"trials":214,"activeCount":62,"soonestReadout":41},[215],{"nctId":39,"briefTitle":40,"status":76,"phases":216,"primaryCompletion":41,"completion":193,"start":194,"enrollment":195,"conditions":217,"interventions":218},[56],[197,198],[42,200],{"trials":220,"activeCount":66},[],{"trials":222,"activeCount":66},[],{"trials":224,"activeCount":66},[],{"intervention":154,"totalTrials":62,"cells":226},{"EARLY_PHASE1":227,"PHASE1":229,"PHASE2":231,"PHASE3":237,"PHASE4":239,"NA":241},{"trials":228,"activeCount":66},[],{"trials":230,"activeCount":66},[],{"trials":232,"activeCount":62,"soonestReadout":46},[233],{"nctId":44,"briefTitle":45,"status":145,"phases":234,"primaryCompletion":46,"completion":147,"start":148,"enrollment":139,"conditions":235,"interventions":236},[56],[150,151,152],[47,154],{"trials":238,"activeCount":66},[],{"trials":240,"activeCount":66},[],{"trials":242,"activeCount":66},[],{"intervention":244,"totalTrials":62,"cells":245},"Remifentanil",{"EARLY_PHASE1":246,"PHASE1":248,"PHASE2":250,"PHASE3":252,"PHASE4":254,"NA":270},{"trials":247,"activeCount":66},[],{"trials":249,"activeCount":66},[],{"trials":251,"activeCount":66},[],{"trials":253,"activeCount":66},[],{"trials":255,"activeCount":66},[256],{"nctId":257,"briefTitle":258,"status":259,"phases":260,"primaryCompletion":261,"completion":261,"start":262,"enrollment":263,"conditions":264,"interventions":268},"NCT03994146","Remifentanil Tapering and Post-adenotonsillectomy Pain in Children","TERMINATED",[58],"2023-08-18","2020-01-16",6,[265,266,267,244],"Child, Only","Pain","Tonsillectomy",[244,269],"Sodium Chloride 9mg\u002FmL",{"trials":271,"activeCount":66},[],{"intervention":269,"totalTrials":62,"cells":273},{"EARLY_PHASE1":274,"PHASE1":276,"PHASE2":278,"PHASE3":280,"PHASE4":282,"NA":288},{"trials":275,"activeCount":66},[],{"trials":277,"activeCount":66},[],{"trials":279,"activeCount":66},[],{"trials":281,"activeCount":66},[],{"trials":283,"activeCount":66},[284],{"nctId":257,"briefTitle":258,"status":259,"phases":285,"primaryCompletion":261,"completion":261,"start":262,"enrollment":263,"conditions":286,"interventions":287},[58],[265,266,267,244],[244,269],{"trials":289,"activeCount":66},[],{"intervention":291,"totalTrials":62,"cells":292},"Hydroxychloroquine Sulfate",{"EARLY_PHASE1":293,"PHASE1":295,"PHASE2":297,"PHASE3":299,"PHASE4":301,"NA":315},{"trials":294,"activeCount":66},[],{"trials":296,"activeCount":66},[],{"trials":298,"activeCount":66},[],{"trials":300,"activeCount":66},[],{"trials":302,"activeCount":66},[303],{"nctId":304,"briefTitle":305,"status":306,"phases":307,"primaryCompletion":308,"completion":309,"start":310,"enrollment":311,"conditions":312,"interventions":314},"NCT04316377","Norwegian Coronavirus Disease 2019 Study","UNKNOWN",[58],"2020-05-25","2025-03-03","2020-03-25",53,[313],"Corona Virus Infection",[291],{"trials":316,"activeCount":66},[],{"intervention":318,"totalTrials":62,"cells":319},"Ibuprofen",{"EARLY_PHASE1":320,"PHASE1":322,"PHASE2":324,"PHASE3":326,"PHASE4":328,"NA":341},{"trials":321,"activeCount":66},[],{"trials":323,"activeCount":66},[],{"trials":325,"activeCount":66},[],{"trials":327,"activeCount":66},[],{"trials":329,"activeCount":66},[330],{"nctId":331,"briefTitle":332,"status":306,"phases":333,"primaryCompletion":334,"completion":335,"start":336,"enrollment":337,"conditions":338,"interventions":340},"NCT05374057","Chiropractic Spinal Manipulative Therapy for Acute Neck Pain",[58],"2023-12-31","2024-08","2022-05-23",320,[339],"Acute Neck Pain",[318],{"trials":342,"activeCount":66},[],{"intervention":344,"totalTrials":62,"cells":345},"Levodopa (drug), intraduodenal administration",{"EARLY_PHASE1":346,"PHASE1":348,"PHASE2":350,"PHASE3":352,"PHASE4":354,"NA":366},{"trials":347,"activeCount":66},[],{"trials":349,"activeCount":66},[],{"trials":351,"activeCount":66},[],{"trials":353,"activeCount":66},[],{"trials":355,"activeCount":66},[356],{"nctId":357,"briefTitle":358,"status":135,"phases":359,"primaryCompletion":360,"completion":360,"start":361,"enrollment":362,"conditions":363,"interventions":365},"NCT00272688","Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit",[58],"2009-05","2006-01",10,[364],"Parkinson Disease",[344],{"trials":367,"activeCount":66},[],{"intervention":369,"totalTrials":62,"cells":370},"Apixaban",{"EARLY_PHASE1":371,"PHASE1":373,"PHASE2":375,"PHASE3":377,"PHASE4":379,"NA":392},{"trials":372,"activeCount":66},[],{"trials":374,"activeCount":66},[],{"trials":376,"activeCount":66},[],{"trials":378,"activeCount":66},[],{"trials":380,"activeCount":66},[381],{"nctId":382,"briefTitle":383,"status":135,"phases":384,"primaryCompletion":385,"completion":385,"start":386,"enrollment":387,"conditions":388,"interventions":391},"NCT02581176","Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study",[58],"2018-05","2016-04",300,[389,390],"Neoplasms","Venous Thrombosis",[369],{"trials":393,"activeCount":66},[],{"intervention":395,"totalTrials":62,"cells":396},"Xiapex",{"EARLY_PHASE1":397,"PHASE1":399,"PHASE2":401,"PHASE3":403,"PHASE4":405,"NA":416},{"trials":398,"activeCount":66},[],{"trials":400,"activeCount":66},[],{"trials":402,"activeCount":66},[],{"trials":404,"activeCount":66},[],{"trials":406,"activeCount":66},[407],{"nctId":408,"briefTitle":409,"status":135,"phases":410,"primaryCompletion":411,"completion":411,"start":412,"enrollment":139,"conditions":413,"interventions":415},"NCT02647619","Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF",[58],"2022-04","2013-10",[414],"Dupuytren Contracture",[395],{"trials":417,"activeCount":66},[],{"intervention":419,"totalTrials":9,"cells":420},"Morphine",{"EARLY_PHASE1":421,"PHASE1":423,"PHASE2":438,"PHASE3":440,"PHASE4":452,"NA":454},{"trials":422,"activeCount":66},[],{"trials":424,"activeCount":66},[425],{"nctId":426,"briefTitle":427,"status":306,"phases":428,"primaryCompletion":429,"completion":430,"start":431,"enrollment":432,"conditions":433,"interventions":435},"NCT04009759","Influence of Morphine or Ketamine or Saline Applied During In-hospital Cardiopulmonary Resuscitation on Early Survival",[55],"2025-01-01","2026-01-01","2021-10-01",240,[434],"Cardiac Arrest",[419,436,437],"Ketamine Injectable Solution","Saline 0.9%",{"trials":439,"activeCount":66},[],{"trials":441,"activeCount":66},[442],{"nctId":443,"briefTitle":444,"status":135,"phases":445,"primaryCompletion":446,"completion":446,"start":447,"enrollment":448,"conditions":449,"interventions":451},"NCT05236647","Subcutaneous Versus Intravenous Morphine When Switching From Oral to Parenteral Route in Palliative Cancer Patients",[57],"2025-01-31","2022-03-08",60,[450],"Pain Cancer",[419],{"trials":453,"activeCount":66},[],{"trials":455,"activeCount":66},[],{"intervention":457,"totalTrials":9,"cells":458},"rosuvastatin",{"EARLY_PHASE1":459,"PHASE1":461,"PHASE2":463,"PHASE3":487,"PHASE4":489,"NA":491},{"trials":460,"activeCount":66},[],{"trials":462,"activeCount":66},[],{"trials":464,"activeCount":66},[465,476],{"nctId":466,"briefTitle":467,"status":468,"phases":469,"primaryCompletion":470,"completion":471,"start":472,"enrollment":66,"conditions":473,"interventions":475},"NCT00951132","Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy","WITHDRAWN",[56],"2012-12","2013-12","2009-09",[474],"Depression",[457],{"nctId":477,"briefTitle":478,"status":135,"phases":479,"primaryCompletion":480,"completion":480,"start":481,"enrollment":482,"conditions":483,"interventions":485},"NCT00929734","Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease",[56],"2014-01","2010-03",99,[484],"Chronic Obstructive Pulmonary Disease (COPD)",[486],"Rosuvastatin",{"trials":488,"activeCount":66},[],{"trials":490,"activeCount":66},[],{"trials":492,"activeCount":66},[],{"intervention":494,"totalTrials":62,"cells":495},"cabazitaxel",{"EARLY_PHASE1":496,"PHASE1":498,"PHASE2":500,"PHASE3":512,"PHASE4":514,"NA":516},{"trials":497,"activeCount":66},[],{"trials":499,"activeCount":66},[],{"trials":501,"activeCount":66},[502],{"nctId":503,"briefTitle":504,"status":259,"phases":505,"primaryCompletion":506,"completion":506,"start":507,"enrollment":508,"conditions":509,"interventions":511},"NCT02478502","Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer",[56],"2022-12-31","2015-06",14,[510],"Testicular Cancer",[494],{"trials":513,"activeCount":66},[],{"trials":515,"activeCount":66},[],{"trials":517,"activeCount":66},[],{"intervention":519,"totalTrials":62,"cells":520},"5-aminolevulinic acid",{"EARLY_PHASE1":521,"PHASE1":523,"PHASE2":525,"PHASE3":537,"PHASE4":539,"NA":541},{"trials":522,"activeCount":66},[],{"trials":524,"activeCount":66},[],{"trials":526,"activeCount":66},[527],{"nctId":528,"briefTitle":529,"status":135,"phases":530,"primaryCompletion":531,"completion":531,"start":532,"enrollment":533,"conditions":534,"interventions":536},"NCT04164849","Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid",[55,56],"2023-10-31","2019-11-22",7,[535],"Crohn Disease",[519],{"trials":538,"activeCount":66},[],{"trials":540,"activeCount":66},[],{"trials":542,"activeCount":66},[],{"intervention":544,"totalTrials":62,"cells":545},"Metoprolol",{"EARLY_PHASE1":546,"PHASE1":548,"PHASE2":550,"PHASE3":562,"PHASE4":564,"NA":566},{"trials":547,"activeCount":66},[],{"trials":549,"activeCount":66},[],{"trials":551,"activeCount":66},[552],{"nctId":553,"briefTitle":554,"status":135,"phases":555,"primaryCompletion":556,"completion":556,"start":557,"enrollment":558,"conditions":559,"interventions":560},"NCT01434134","Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy",[56],"2014-09","2011-09",130,[18,15],[544,561],"Candesartan",{"trials":563,"activeCount":66},[],{"trials":565,"activeCount":66},[],{"trials":567,"activeCount":66},[],{"intervention":561,"totalTrials":62,"cells":569},{"EARLY_PHASE1":570,"PHASE1":572,"PHASE2":574,"PHASE3":580,"PHASE4":582,"NA":584},{"trials":571,"activeCount":66},[],{"trials":573,"activeCount":66},[],{"trials":575,"activeCount":66},[576],{"nctId":553,"briefTitle":554,"status":135,"phases":577,"primaryCompletion":556,"completion":556,"start":557,"enrollment":558,"conditions":578,"interventions":579},[56],[18,15],[544,561],{"trials":581,"activeCount":66},[],{"trials":583,"activeCount":66},[],{"trials":585,"activeCount":66},[],{"intervention":587,"totalTrials":62,"cells":588},"Letrozole 2.5mg oral tablet; Ribociclib 600mg oral",{"EARLY_PHASE1":589,"PHASE1":591,"PHASE2":593,"PHASE3":610,"PHASE4":612,"NA":614},{"trials":590,"activeCount":66},[],{"trials":592,"activeCount":66},[],{"trials":594,"activeCount":66},[595],{"nctId":596,"briefTitle":597,"status":135,"phases":598,"primaryCompletion":599,"completion":599,"start":600,"enrollment":601,"conditions":602,"interventions":608},"NCT05163106","Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole",[56],"2024-07-30","2022-12-01",85,[18,603,604,605,606,607],"HER2-negative Breast Cancer","ER-positive Breast Cancer","Locally Advanced Breast Cancer","Luminal A Breast Cancer","Luminal B Breast Cancer",[587,609],"Goserelin",{"trials":611,"activeCount":66},[],{"trials":613,"activeCount":66},[],{"trials":615,"activeCount":66},[],{"intervention":609,"totalTrials":62,"cells":617},{"EARLY_PHASE1":618,"PHASE1":620,"PHASE2":622,"PHASE3":628,"PHASE4":630,"NA":632},{"trials":619,"activeCount":66},[],{"trials":621,"activeCount":66},[],{"trials":623,"activeCount":66},[624],{"nctId":596,"briefTitle":597,"status":135,"phases":625,"primaryCompletion":599,"completion":599,"start":600,"enrollment":601,"conditions":626,"interventions":627},[56],[18,603,604,605,606,607],[587,609],{"trials":629,"activeCount":66},[],{"trials":631,"activeCount":66},[],{"trials":633,"activeCount":66},[],{"intervention":143,"totalTrials":62,"cells":635},{"EARLY_PHASE1":636,"PHASE1":638,"PHASE2":640,"PHASE3":646,"PHASE4":648,"NA":650},{"trials":637,"activeCount":66},[],{"trials":639,"activeCount":66},[],{"trials":641,"activeCount":66},[642],{"nctId":133,"briefTitle":134,"status":135,"phases":643,"primaryCompletion":137,"completion":137,"start":138,"enrollment":139,"conditions":644,"interventions":645},[56],[141],[47,143],{"trials":647,"activeCount":66},[],{"trials":649,"activeCount":66},[],{"trials":651,"activeCount":66},[],{"intervention":436,"totalTrials":62,"cells":653},{"EARLY_PHASE1":654,"PHASE1":656,"PHASE2":662,"PHASE3":664,"PHASE4":666,"NA":668},{"trials":655,"activeCount":66},[],{"trials":657,"activeCount":66},[658],{"nctId":426,"briefTitle":427,"status":306,"phases":659,"primaryCompletion":429,"completion":430,"start":431,"enrollment":432,"conditions":660,"interventions":661},[55],[434],[419,436,437],{"trials":663,"activeCount":66},[],{"trials":665,"activeCount":66},[],{"trials":667,"activeCount":66},[],{"trials":669,"activeCount":66},[],{"intervention":437,"totalTrials":62,"cells":671},{"EARLY_PHASE1":672,"PHASE1":674,"PHASE2":680,"PHASE3":682,"PHASE4":684,"NA":686},{"trials":673,"activeCount":66},[],{"trials":675,"activeCount":66},[676],{"nctId":426,"briefTitle":427,"status":306,"phases":677,"primaryCompletion":429,"completion":430,"start":431,"enrollment":432,"conditions":678,"interventions":679},[55],[434],[419,436,437],{"trials":681,"activeCount":66},[],{"trials":683,"activeCount":66},[],{"trials":685,"activeCount":66},[],{"trials":687,"activeCount":66},[],{"intervention":689,"totalTrials":62,"cells":690},"Elbasvir \u002F Grazoprevir Oral",{"EARLY_PHASE1":691,"PHASE1":693,"PHASE2":695,"PHASE3":697,"PHASE4":699,"NA":701},{"trials":692,"activeCount":66},[],{"trials":694,"activeCount":66},[],{"trials":696,"activeCount":66},[],{"trials":698,"activeCount":66},[],{"trials":700,"activeCount":66},[],{"trials":702,"activeCount":66},[703],{"nctId":704,"briefTitle":705,"status":306,"phases":706,"primaryCompletion":707,"completion":708,"start":709,"enrollment":387,"conditions":710,"interventions":712},"NCT04063839","HCV Treatment in a Low-threshold Clinic",[],"2019-10-31","2022-12","2015-01",[711,25],"Hepatitis C",[689]]